Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chunyang Jin
FL118, a Novel Camptothecin Derivative, Is Insensitive to ABCG2 Expression and Shows Improved Efficacy in Comparison With Irinotecan in Colon and Lung Cancer Models With ABCG2-induced Resistance
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Development and Validation of a High-Throughput Calcium Mobilization Assay for the Orphan Receptor GPR88
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Related publications
Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump
Molecular Cancer Therapeutics
Cancer Research
Oncology
Breast Cancer Resistance Protein BCRP/ABCG2 Regulatory microRNAs (Hsa-miR-328, -519c and -520h) and Their Differential Expression in Stem-Like ABCG2+ Cancer Cells
Biochemical Pharmacology
Biochemistry
Pharmacology
A Novel Synthetic Dihydroindeno[1,2-B] Indole Derivative (LS-2-3j) Reverses ABCB1- And ABCG2-Mediated Multidrug Resistance in Cancer Cells
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Breast Cancer, Side Population Cells and ABCG2 Expression
Cancer Letters
Cancer Research
Oncology
Breast Cancer Resistance Protein (BCRP/ABCG2): Its Role in Multidrug Resistance and Regulation of Its Gene Expression
Chinese Journal of Cancer
FGFR1 Cooperates With EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Increased Expression of Metallothionein Is Associated With Irinotecan Resistance in Gastric Cancer
Cancer Research
Cancer Research
Oncology
ISO-66, a Novel Inhibitor of Macrophage Migration Inhibitory Factor, Shows Efficacy in Melanoma and Colon Cancer Models
International Journal of Oncology
Cancer Research
Oncology
Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts
Molecular Cancer Therapeutics
Cancer Research
Oncology